Classification of current anticancer immunotherapiesLorenzo Galluzzi, Enrico Lugli, Guido Kroemer et al.|Oncotarget|2014Cited by 469
Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathyJithendra Kini Bailur, Madhav V. Dhodapkar|JCI Insight|2019Cited by 167
Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy BiomarkersLisa H. Butterfield, Mary L. Disis, A. Karolina Palucka et al.|Clinical Cancer Research|2011Cited by 109
Natural immunity to pluripotency antigen OCT4 in humansKavita M. Dhodapkar, Madhav V. Dhodapkar|Proceedings of the National Academy of Sciences|2010Cited by 90
Checkpoint Inhibition in Myeloma: Opportunities and ChallengesFederica Costa, Madhav V. Dhodapkar|Frontiers in Immunology|2018Cited by 62